Examples of how the pharmaceutical industries distort the evidence of drug safety: the case of pioglitazone and the bladder cancer issue

Journal article

Open access

Peer reviewed

Jean-Luc Faillie and Dominique Hillaire-Buys

Pharmacoepidemiology and Drug Safety, Vol.25(2), pp.212 - 214

02/2016

PMID: 26617411

Abstract

drug safety

pharmaceutical industry

pharmacoepidemiology

pharmacovigilance

pioglitazone

url

Find in HALView

1 Record Views

Title: Examples of how the pharmaceutical industries distort the evidence of drug safety: the case of pioglitazone and the bladder cancer issue
Creators - without role: Jean-Luc Faillie - Centre Hospitalier Régional Universitaire [Montpellier]
Dominique Hillaire-Buys - Centre Hospitalier Universitaire de Montpellier
Publication Details: Pharmacoepidemiology and Drug Safety, Vol.25(2), pp.212 - 214
Identifiers: 9946001109311
Academic Unit: Institut Desbrest d Epidemiologie et de Sante Publique - IDESP
Language: English
Resource Type: Journal article
Local Fields: hal-01886850